Patents by Inventor Tatiana Vener

Tatiana Vener has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10407718
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including a method of preventing a significant reduction in duplexes detectable in a hybridization assay involving (i) selecting probe lengths for sets of oligonucleotide probes, wherein probes include different subsequences such that at least one subsequence is complementary to a subsequence in a cognate target; wherein probes for longer cognate targets are longer in length than probes for shorter cognate targets, (ii) selecting, for each set of probes, a density of oligonucleotides probes attached per unit area on a solid phase carrier which is below a limit at which the significant reduction in detectable duplexes is predicated to take place, (iii) producing the probes and affixing them to different solid phase carriers at the selected density, and (iv) annealing targets to the probes, wherein signal intensities of probes and targets of different lengths are about the same.
    Type: Grant
    Filed: April 19, 2017
    Date of Patent: September 10, 2019
    Assignee: BioArray Solutions Ltd.
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Publication number: 20170218437
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including: methods of probe and target “engineering”, as well as methods of assay signal analysis relating to the modulation of the probe-target affinity constant, K by a variety of factors including the elastic properties of target strands and layers of immobilized (“grafted”) probes; and assay methodologies relating to: the tuning of assay signal intensities including dynamic range compression and on-chip signal amplification; the combination of hybridization-mediated and elongation-mediated detection for the quantitative determination of abundance of messages displaying a high degree of sequence similarity, including, for example, the simultaneous determination of the relative expression levels, and identification of the specific class of, untranslated AU-rich subsequences located near the 3? terminus of mRNA; and a new method of subtractive differential gene expression analysis which requires only a single color label.
    Type: Application
    Filed: April 19, 2017
    Publication date: August 3, 2017
    Inventors: Michael SEUL, Sukanta Banerjee, Jiacheng YANG, Tatiana Vener
  • Patent number: 9637777
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including a method of preventing a significant reduction in duplexes detectable in a hybridization assay involving (i) selecting probe lengths for sets of oligonucleotide probes, wherein probes include different subsequences such that at least one subsequence is complementary to a subsequence in a cognate target; wherein probes for longer cognate targets are longer in length than probes for shorter cognate targets, (ii) selecting, for each set of probes, a density of oligonucleotides probes attached per unit area on a solid phase carrier which is below a limit at which the significant reduction in detectable duplexes is predicated to take place, (iii) producing the probes and affixing them to different solid phase carriers at the selected density, and (iv) annealing targets to the probes, wherein signal intensities of probes and targets of different lengths are about the same.
    Type: Grant
    Filed: April 21, 2014
    Date of Patent: May 2, 2017
    Assignee: BioArray Solutions, Ltd.
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Publication number: 20170088885
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including a method of preventing a significant reduction in duplexes detectable in a hybridization assay involving (i) selecting probe lengths for sets of oligonucleotide probes, wherein probes include different subsequences such that at least one subsequence is complementary to a subsequence in a cognate target; wherein probes for longer cognate targets are longer in length than probes for shorter cognate targets, (ii) selecting, for each set of probes, a density of oligonucleotides probes attached per unit area on a solid phase carrier which is below a limit at which the significant reduction in detectable duplexes is predicated to take place, (iii) producing the probes and affixing them to different solid phase carriers at the selected density, and (iv) annealing targets to the probes, wherein signal intensities of probes and targets of different lengths are about the same.
    Type: Application
    Filed: April 21, 2014
    Publication date: March 30, 2017
    Applicant: BIOARRAY SOLUTIONS, LTD.
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Publication number: 20160215327
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including a method of preventing a significant reduction in duplexes detectable in a hybridization assay involving (i) selecting probe lengths for sets of oligonucleotide probes, wherein probes include different subsequences such that at least one subsequence is complementary to a subsequence in a cognate target; wherein probes for longer cognate targets are longer in length than probes for shorter cognate targets, (ii) selecting, for each set of probes, a density of oligonucleotides probes attached per unit area on a solid phase carrier which is below a limit at which the significant reduction in detectable duplexes is predicated to take place, (iii) producing the probes and affixing them to different solid phase carriers at the selected density, and (iv) annealing targets to the probes, wherein signal intensities of probes and targets of different lengths are about the same.
    Type: Application
    Filed: April 21, 2014
    Publication date: July 28, 2016
    Applicant: BIOARRAY SOLUTIONS, LTD.
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Publication number: 20160138103
    Abstract: Methods are disclosed for the identification of gene sets that are differentially expressed in PBMCs of patients diagnosed with a pre-diabetic disease state and overt type II diabetes. 3 gene and 10 gene signatures are shown to accurately predict a diabetic disease state in a patient. The application also described kits for the rapid diagnosis of diabetic disease states in patients at a point of care facility.
    Type: Application
    Filed: May 13, 2015
    Publication date: May 19, 2016
    Inventors: John F. Palma, John W. Backus, Yixin Wang, Jack X. Yu, Yi Zhang, Tatiana Vener, Carlo Derechio, Dong U. Lee
  • Publication number: 20140315192
    Abstract: Methods and kits for predicting the course or aggressiveness of prostate cancer include detecting the methylation status of various genes.
    Type: Application
    Filed: March 6, 2013
    Publication date: October 23, 2014
    Applicant: Veridex, LLC
    Inventors: HAIYING WANG, SHOBHA VARDE, DONDAPATI CHOWDARY, JYOTI MEHROTRA, TATIANA VENER, ABHIJIT MAZUMDER
  • Patent number: 8795960
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including: methods of probe and target “engineering”, as well as methods of assay signal analysis relating to the modulation of the probe-target affinity constant, K by a variety of factors including the elastic properties of target strands and layers of immobilized (“grafted”) probes; and assay methodologies relating to: the tuning of assay signal intensities including dynamic range compression and on-chip signal amplification; the combination of hybridization-mediated and elongation-mediated detection for the quantitative determination of abundance of messages displaying a high degree of sequence similarity, including, for example, the simultaneous determination of the relative expression levels, and identification of the specific class of, untranslated AU-rich subsequences located near the 3? terminus of mRNA; and a new method of subtractive differential gene expression analysis which requires only a single color label.
    Type: Grant
    Filed: June 8, 2009
    Date of Patent: August 5, 2014
    Assignee: Bioarray Solutions, Ltd.
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Publication number: 20120190585
    Abstract: Disclosed is a method of iteratively optimizing two (or more) interrelated sets of probes for the multi-step analysis of sets of designated sequences, each such sequence requiring, for conversion, at least one conversion probe (“primer”), and each converted sequence requiring, for detection, at least one capture probe. The iterative method disclosed herein for the concurrent optimization of primer and probe selection invokes fast logical string matching functions to perform a complete cross-correlation of probe sequences and target sequences. The score function assigns to each probe-target alignment a “degree of matching” score on the basis of position-weighted Hamming distance functions introduced herein. Pairs of probes in the final selection may differ in several positions, while other pairs of probes may differ in only a single position. Not all such positions are of equal importance, and a score function is introduced, reflecting the position of the mismatch within the probe sequence.
    Type: Application
    Filed: June 27, 2011
    Publication date: July 26, 2012
    Applicant: BioArray Solutions, Ltd.
    Inventors: Michael Seul, Tatiana Vener, Xiongwu Xia
  • Publication number: 20110275079
    Abstract: Methods are disclosed for the identification of gene sets that are differentially expressed in PBMCs of patients diagnosed with a pre-diabetic disease state and overt type II diabetes. 3 gene and 10 gene signatures are shown to accurately predict a diabetic disease state in a patient. The application also described kits for the rapid diagnosis of diabetic disease states in patients at a point of care facility.
    Type: Application
    Filed: November 13, 2008
    Publication date: November 10, 2011
    Inventors: John F. Palma, John W. Backus, Yixin Wang, Jack X. Yu, Yi Zhang, Tatiana Vener, Carlo Derecho, Dong U. Lee
  • Patent number: 7970553
    Abstract: Disclosed is a method of iteratively optimizing two (or more) interrelated sets of probes for the multi-step analysis of sets of designated sequences, each such sequence requiring, for conversion, at least one conversion probe (“primer”), and each converted sequence requiring, for detection, at least one capture probe. The iterative method disclosed herein for the concurrent optimization of primer and probe selection invokes fast logical string matching functions to perform a complete cross-correlation of probe sequences and target sequences. The score function assigns to each probe-target alignment a “degree of matching” score on the basis of position-weighted Hamming distance functions introduced herein. Pairs of probes in the final selection may differ in several positions, while other pairs of probes may differ in only a single position. Not all such positions are of equal importance, and a score function is introduced, reflecting the position of the mismatch within the probe sequence.
    Type: Grant
    Filed: July 14, 2009
    Date of Patent: June 28, 2011
    Assignee: BioArray Solutions, Ltd.
    Inventors: Michael Seul, Tatiana Vener, Xiongwu Xia
  • Publication number: 20110009288
    Abstract: An assay for identifying early stage malignant melanocyte in biopsy tissues is provided by determining whether differential expression of a particular gene indicative of melanoma exceed a cut-off value.
    Type: Application
    Filed: July 8, 2010
    Publication date: January 13, 2011
    Inventors: Dmitri TALANTOV, John F. Palma, Tatiana Vener, Tim Jatkoe, Haiying Wang, Yixin Wang
  • Publication number: 20100081145
    Abstract: Methods and kits for detecting prostate cancer in urine samples include detecting the methylation status of various genes.
    Type: Application
    Filed: December 1, 2009
    Publication date: April 1, 2010
    Inventors: Haiying Wang, Jonathan F. Baden, Tatiana Vener, Dondapati Chowdary, Abhijit Mazumder
  • Publication number: 20100021909
    Abstract: Disclosed is a method of iteratively optimizing two (or more) interrelated sets of probes for the multi-step analysis of sets of designated sequences, each such sequence requiring, for conversion, at least one conversion probe (“primer”), and each converted sequence requiring, for detection, at least one capture probe. The iterative method disclosed herein for the concurrent optimization of primer and probe selection invokes fast logical string matching functions to perform a complete cross-correlation of probe sequences and target sequences. The score function assigns to each probe-target alignment a “degree of matching” score on the basis of position-weighted Hamming distance functions introduced herein. Pairs of probes in the final selection may differ in several positions, while other pairs of probes may differ in only a single position. Not all such positions are of equal importance, and a score function is introduced, reflecting the position of the mismatch within the probe sequence.
    Type: Application
    Filed: July 14, 2009
    Publication date: January 28, 2010
    Inventors: Michael Seul, Tatiana Vener, XiongWu Xia
  • Publication number: 20090263820
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including: methods of probe and target “engineering”, as well as methods of assay signal analysis relating to the modulation of the probe-target affinity constant, K by a variety of factors including the elastic properties of target strands and layers of immobilized (“grafted”) probes; and assay methodologies relating to: the tuning of assay signal intensities including dynamic range compression and on-chip signal amplification; the combination of hybridization-mediated and elongation-mediated detection for the quantitative determination of abundance of messages displaying a high degree of sequence similarity, including, for example, the simultaneous determination of the relative expression levels, and identification of the specific class of, untranslated AU-rich subsequences located near the 3? terminus of mRNA; and a new method of subtractive differential gene expression analysis which requires only a single color label.
    Type: Application
    Filed: June 8, 2009
    Publication date: October 22, 2009
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Patent number: 7574305
    Abstract: Disclosed is a method of iteratively optimizing two (or more) interrelated sets of probes for the multi-step analysis of sets of designated sequences, each such sequence requiring, for conversion, at least one conversion probe (“primer”), and each converted sequence requiring, for detection, at least one capture probe. The iterative method disclosed herein for the concurrent optimization of primer and probe selection invokes fast logical string matching functions to perform a complete cross-correlation of probe sequences and target sequences. The score function assigns to each probe-target alignment a “degree of matching” score on the basis of position-weighted Hamming distance functions introduced herein. Pairs of probes in the final selection may differ in several positions, while other pairs of probes may differ in only a single position. Not all such positions are of equal importance, and a score function is introduced, reflecting the position of the mismatch within the probe sequence.
    Type: Grant
    Filed: July 15, 2004
    Date of Patent: August 11, 2009
    Assignee: Bioarray Solutions Ltd.
    Inventors: Michael Seul, Tatiana Vener, Xiongwu Xia
  • Patent number: 7563569
    Abstract: Disclosed are methods of multiplexed analysis of oligonucleotides in a sample, including: methods of probe and target “engineering”, as well as methods of assay signal analysis relating to the modulation of the probe-target affinity constant, K by a variety of factors including the elastic properties of target strands and layers of immobilized (“grafted”) probes; and assay methodologies relating to: the tuning of assay signal intensities including dynamic range compression and on-chip signal amplification; the combination of hybridization-mediated and elongation-mediated detection for the quantitative determination of abundance of messages displaying a high degree of sequence similarity, including, for example, the simultaneous determination of the relative expression levels, and identification of the specific class of, untranslated AU-rich subsequences located near the 3? terminus of mRNA; and a new method of subtractive differential gene expression analysis which requires only a single color label.
    Type: Grant
    Filed: October 26, 2004
    Date of Patent: July 21, 2009
    Inventors: Michael Seul, Sukanta Banerjee, Jiacheng Yang, Tatiana Vener
  • Publication number: 20090047656
    Abstract: The present invention provides a method of propagating cells of interest obtained from a biological specimen by a) enriching the cells under conditions that maintain sufficient cell viability; and b) propagating the cells under conditions effective to allow cell viability, proliferation and integrity.
    Type: Application
    Filed: March 13, 2007
    Publication date: February 19, 2009
    Inventors: Jonathan F. Baden, Chang H. Choi, Dondapati Chowdary, Kathleen M. Curtin, Tatiana Vener, Haiying Wang, Christine A. Burnett, Abhijit Mazumder
  • Publication number: 20080254455
    Abstract: Methods and kits for detecting prostate cancer in urine samples include detecting the methylation status of various genes.
    Type: Application
    Filed: April 12, 2007
    Publication date: October 16, 2008
    Inventors: Haiying Wang, Jonathan F. Baden, Tatiana Vener, Dondapati Chowdary, Abhijit Mazumder
  • Publication number: 20070059753
    Abstract: Methods, kits, and compositions for detecting the methylation status of various genes are useful in various diagnostic applications involving suspected proliferative disorders such as prostate cancer.
    Type: Application
    Filed: September 13, 2006
    Publication date: March 15, 2007
    Inventors: Tatiana Vener, Jyoti Mehrotra, Shobha Varde, Abhijit Mazumder, Jon Baden, John Backus